Chemotherapy and Physical Therapeutics Modulate Antigens on Cancer Cells

Cancer cells possess specific properties, such as multidrug resistance or unlimited proliferation potential, due to the presence of specific proteins on their cell membranes. The release of proliferation-related proteins from the membrane can evoke a loss of adaptive ability in cancer cells and thus...

Full description

Bibliographic Details
Main Authors: Wojciech Szlasa, Natalia Janicka, Natalia Sauer, Olga Michel, Bernadetta Nowak, Jolanta Saczko, Julita Kulbacka
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-07-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.889950/full
_version_ 1818159423365840896
author Wojciech Szlasa
Natalia Janicka
Natalia Sauer
Olga Michel
Bernadetta Nowak
Jolanta Saczko
Julita Kulbacka
author_facet Wojciech Szlasa
Natalia Janicka
Natalia Sauer
Olga Michel
Bernadetta Nowak
Jolanta Saczko
Julita Kulbacka
author_sort Wojciech Szlasa
collection DOAJ
description Cancer cells possess specific properties, such as multidrug resistance or unlimited proliferation potential, due to the presence of specific proteins on their cell membranes. The release of proliferation-related proteins from the membrane can evoke a loss of adaptive ability in cancer cells and thus enhance the effects of anticancer therapy. The upregulation of cancer-specific membrane antigens results in a better outcome of immunotherapy. Moreover, cytotoxic T-cells may also become more effective when stimulated ex-vivo toward the anticancer response. Therefore, the modulation of membrane proteins may serve as an interesting attempt in anticancer therapy. The presence of membrane antigens relies on various physical factors such as temperature, exposure to radiation, or drugs. Therefore, changing the tumor microenvironment conditions may lead to cancer cells becoming sensitized to subsequent therapy. This paper focuses on the therapeutic approaches modulating membrane antigens and enzymes in anticancer therapy. It aims to analyze the possible methods for modulating the antigens, such as pharmacological treatment, electric field treatment, photodynamic reaction, treatment with magnetic field or X-ray radiation. Besides, an overview of the effects of chemotherapy and immunotherapy on the immunophenotype of cancer cells is presented. Finally, the authors review the clinical trials that involved the modulation of cell immunophenotype in anticancer therapy.
first_indexed 2024-12-11T15:45:45Z
format Article
id doaj.art-a8274989afa54e0e85e1b716c8e0fe86
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-12-11T15:45:45Z
publishDate 2022-07-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-a8274989afa54e0e85e1b716c8e0fe862022-12-22T00:59:42ZengFrontiers Media S.A.Frontiers in Immunology1664-32242022-07-011310.3389/fimmu.2022.889950889950Chemotherapy and Physical Therapeutics Modulate Antigens on Cancer CellsWojciech Szlasa0Natalia Janicka1Natalia Sauer2Olga Michel3Bernadetta Nowak4Jolanta Saczko5Julita Kulbacka6Faculty of Medicine, Wroclaw Medical University, Wroclaw, PolandFaculty of Pharmacy, Wroclaw Medical University, Wroclaw, PolandFaculty of Pharmacy, Wroclaw Medical University, Wroclaw, PolandDepartment of Molecular and Cellular Biology, Faculty of Pharmacy, Wroclaw Medical University, Wroclaw, PolandFaculty of Medicine, Wroclaw Medical University, Wroclaw, PolandDepartment of Molecular and Cellular Biology, Faculty of Pharmacy, Wroclaw Medical University, Wroclaw, PolandDepartment of Molecular and Cellular Biology, Faculty of Pharmacy, Wroclaw Medical University, Wroclaw, PolandCancer cells possess specific properties, such as multidrug resistance or unlimited proliferation potential, due to the presence of specific proteins on their cell membranes. The release of proliferation-related proteins from the membrane can evoke a loss of adaptive ability in cancer cells and thus enhance the effects of anticancer therapy. The upregulation of cancer-specific membrane antigens results in a better outcome of immunotherapy. Moreover, cytotoxic T-cells may also become more effective when stimulated ex-vivo toward the anticancer response. Therefore, the modulation of membrane proteins may serve as an interesting attempt in anticancer therapy. The presence of membrane antigens relies on various physical factors such as temperature, exposure to radiation, or drugs. Therefore, changing the tumor microenvironment conditions may lead to cancer cells becoming sensitized to subsequent therapy. This paper focuses on the therapeutic approaches modulating membrane antigens and enzymes in anticancer therapy. It aims to analyze the possible methods for modulating the antigens, such as pharmacological treatment, electric field treatment, photodynamic reaction, treatment with magnetic field or X-ray radiation. Besides, an overview of the effects of chemotherapy and immunotherapy on the immunophenotype of cancer cells is presented. Finally, the authors review the clinical trials that involved the modulation of cell immunophenotype in anticancer therapy.https://www.frontiersin.org/articles/10.3389/fimmu.2022.889950/fullantigensmembranemodulationanticancer therapycancer
spellingShingle Wojciech Szlasa
Natalia Janicka
Natalia Sauer
Olga Michel
Bernadetta Nowak
Jolanta Saczko
Julita Kulbacka
Chemotherapy and Physical Therapeutics Modulate Antigens on Cancer Cells
Frontiers in Immunology
antigens
membrane
modulation
anticancer therapy
cancer
title Chemotherapy and Physical Therapeutics Modulate Antigens on Cancer Cells
title_full Chemotherapy and Physical Therapeutics Modulate Antigens on Cancer Cells
title_fullStr Chemotherapy and Physical Therapeutics Modulate Antigens on Cancer Cells
title_full_unstemmed Chemotherapy and Physical Therapeutics Modulate Antigens on Cancer Cells
title_short Chemotherapy and Physical Therapeutics Modulate Antigens on Cancer Cells
title_sort chemotherapy and physical therapeutics modulate antigens on cancer cells
topic antigens
membrane
modulation
anticancer therapy
cancer
url https://www.frontiersin.org/articles/10.3389/fimmu.2022.889950/full
work_keys_str_mv AT wojciechszlasa chemotherapyandphysicaltherapeuticsmodulateantigensoncancercells
AT nataliajanicka chemotherapyandphysicaltherapeuticsmodulateantigensoncancercells
AT nataliasauer chemotherapyandphysicaltherapeuticsmodulateantigensoncancercells
AT olgamichel chemotherapyandphysicaltherapeuticsmodulateantigensoncancercells
AT bernadettanowak chemotherapyandphysicaltherapeuticsmodulateantigensoncancercells
AT jolantasaczko chemotherapyandphysicaltherapeuticsmodulateantigensoncancercells
AT julitakulbacka chemotherapyandphysicaltherapeuticsmodulateantigensoncancercells